Tech Capital IndexAbtrace
StartupUses machine learning and NLP to reshape the delivery of primary care.
Employees: 23
LTCI™Tech Capital Index
Clues Intelligence LTD
Clues Intelligence LTD
28 organisations matching 1 filter
Uses machine learning and NLP to reshape the delivery of primary care.
AI medical imaging company using deep learning for lung cancer detection from CT scans.
Building a 'GPT for Biology' by collecting DNA samples from biodiverse ecosystems worldwide, constructing a massive proprietary database of nature's genetic data.
London-headquartered AI drug discovery platform integrating biological data with machine learning to identify novel drug targets and optimise molecule design.
Academic research group in contextual AI for computer-assisted interventions and medical imaging.
London-based biomedical AI platform using NLP to extract causal biomedical relationships from vast scientific literature, accelerating target identification.
London-based health tech company that uses AI to provide predictive healthcare services and enhance home care for the elderly.
AI-driven home healthcare. Launched predictive model in March 2026 to identify patient deterioration 48 hours in advance. Used by 5,000+ carers in London.
Charm Therapeutics uses 3D deep learning to predict how drug molecules and target proteins co-fold together, enabling design of therapeutics.
DeepMind conducts healthcare AI research, e.g. AlphaFold for protein structure and diagnostics.
AI solution for dental applications, presented at London AI Hub event on March 24 2026.
London-based agentic AI rostering platform for the NHS, automating staff scheduling across NHS Trusts to cut agency costs and improve staffing efficie...
Uses ML to identify patients for proactive health coaching.
London-based digital health platform using AI and wearable technology to collect real-time patient data, detect digital biomarkers, and support clinical trials.
AI drug discovery company focused on immunology and inflammation therapeutics, using machine learning to identify novel therapeutic targets.
Develops deep learning software to help radiologists detect breast cancer earlier and more accurately.
London-based AI company specialising in deep learning for breast cancer detection; its flagship product Mia® (Mammography Intelligent Assessment) assists radiologists.
Applies deep learning to medical imaging to improve the early detection of breast cancer.
LabGenius is a synthetic biology company that uses machine learning, DNA synthesis, and robotics to discover novel therapeutic antibodies.
London-based clinical AI company providing the leading mental health triage product for the NHS; its chatbot Limbic Access diagnoses conditions with high accuracy.
London-based mental health AI company building clinically validated AI tools to support psychological therapy services — partnering with NHS mental he...
AI for early lung cancer diagnosis. NHS England adopted Optellum's Virtual Nodule Clinic in March 2026, reducing false positives by 60%.
AI platform targeting intrinsically disordered proteins for drug discovery. Addresses challenging protein targets for new therapeutics.
Originally founded as Exscientia in London/Oxford and now merged with Recursion Pharmaceuticals, a pioneer in AI-designed drug candidates.